4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-24-001268
EVP, COO, Head of Commercial sold 731 shares at $29.96 ($21,901)
- EVP, COO, Head of Commercial acquired 1,287 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, Head of Commercial | 2024-01-06 | Option exercise | +1,287 | 31,680 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2024-01-08 | Sale | −731 | $29.96 | $21,901 | 30,949 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, Head of Commercial | 2024-01-06 | Option exercise · Restricted Stock Units | −1,287 | 0 | D | ||
| Open-market sales · 731 sh · avg $29.96 · $21,901 | |||||||
Loading xslF345X05/doc4.xml…